Eight Northwestern researchers published a study April 29 detailing how RNA therapy could be used before birth to combat a ...
After a heart attack, cardiologists can reopen blocked vessels and restore blood flow, but the muscle cells that died will never be replaced. The heart is one of the organs with the least ability to ...
Rznomics a biopharmaceutical company specializing in RNA-based gene therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy ...
Scientists have developed a new therapy designed to repair cardiac damage after a heart attack. The study, led by researchers at Columbia University and published in the journal Nature Biomedical ...
Morning Overview on MSN
RNA-based therapy reaches proof-of-concept for autism-related gene mutations in preclinical models
A single injection into the bloodstream of a mouse corrected a mutation linked to autism in neurons throughout the brain and ...
A particular protein deficiency that leads to liver and lung damage is currently treatable only with decades-old therapies that all have limitations. Biotech startup AIRNA is part of a field of ...
A new possibility for managing cardiovascular disease through RNA interference (RNAi) gene therapies. As cardiovascular diseases continue to be the leading cause of death globally, this technology ...
Immunofluorescence image of transverse heart sections from a healthy neonatal mouse (Left) or a neonatal mouse in which myocardial infarction was induced at postnatal day 1, examined 3 days after ...
In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small interfering RNA therapy with an immunomodulator led to substantial declines in blood ...
A developer of RNA editing therapies whose lead program targets Alpha-1 antitrypsin deficiency (AATD) said today it has closed an oversubscribed $60 million Series A financing, with plans that include ...
A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results